0001104659-23-005476.txt : 20230120
0001104659-23-005476.hdr.sgml : 20230120
20230120173836
ACCESSION NUMBER: 0001104659-23-005476
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230118
FILED AS OF DATE: 20230120
DATE AS OF CHANGE: 20230120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hoffman Michael B
CENTRAL INDEX KEY: 0001290208
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39202
FILM NUMBER: 23542064
BUSINESS ADDRESS:
BUSINESS PHONE: (203) 413-2200
MAIL ADDRESS:
STREET 1: 1 GREENWICH OFFICE PARK
CITY: GREENWICH
STATE: CT
ZIP: 06831
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Annovis Bio, Inc.
CENTRAL INDEX KEY: 0001477845
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262540421
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1055 WESTLAKES DRIVE, SUITE 300
CITY: BERWYN
STATE: PA
ZIP: 19312
BUSINESS PHONE: 610-727-3913
MAIL ADDRESS:
STREET 1: 1055 WESTLAKES DRIVE, SUITE 300
CITY: BERWYN
STATE: PA
ZIP: 19312
FORMER COMPANY:
FORMER CONFORMED NAME: QR Pharma, Inc.
DATE OF NAME CHANGE: 20091202
4
1
tm234043-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2023-01-18
0
0001477845
Annovis Bio, Inc.
ANVS
0001290208
Hoffman Michael B
C/O ANNOVIS BIO, INC.
1055 WESTLAKES DRIVE, SUITE 300
BERWYN
PA
19312
1
0
1
0
Stock Option (right to buy)
13.17
2023-01-18
4
A
0
6820
0
A
2033-01-18
Common Stock
6820
6820
D
The stock option shall vest in eight consecutive equal quarterly installments each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025.
/s/ Henry Hagopian III, Attorney-in-Fact for Michael Hoffman
2023-01-20